Material Insights · Understanding the Material World

Monoclonal antibodies

Identical antibodies made by cloned cells target one molecule, for drugs and tests.

Health and medicine · Biotechnology · No. 194

  • Digital age
  • Readiness 9 of 9
  • Process
Health and medicine · Technology

Fusing an antibody-making cell with a cancer cell in 1975 gave medicine an endless supply of identical, made-to-order antibodies.

Chart: Illustration: Monoclonal antibodies

Where it comes from

Chart: Map of where it comes from

Georges Köhler and César Milstein fused antibody-making cells with tumour cells in 1975. The fused cells lived on and kept making one antibody, and the pair shared the 1984 Nobel Prize.

Three things to know
  1. The first antibody medicine, approved in 1986, was a mouse protein, and patients' immune systems often attacked it.
  2. Chimeric antibodies followed in 1994, humanised ones in 1997 and fully human ones in 2002.
  3. In 2024 alone, 21 antibody medicines won a first approval somewhere in the world.
The journey
  1. 1 TargetPick one molecule, such as a protein on a cancer cell
  2. 2 Immune cellsFind cells that make an antibody against it
  3. 3 CloningMake those cells immortal so one line keeps making the same antibody
  4. 4 EngineeringMake the antibody more human so the body accepts it
  5. 5 Medicine or testProduce, purify and approve it for patients or laboratories
Covered in Pharmaceuticals and fermentation: from molecule to medicineChemicals
Go deeper pick a tab to open it in full